Mitochondrial myopathy caused by clevudine therapy in chronic hepatitis B patients
- 27 August 2009
- journal article
- research article
- Published by Wiley in Hepatology Research
- Vol. 39 (9) , 944-947
Abstract
As a pyrimidine analog with potent and sustained antiviral activity against hepatitis B virus, clevudine has been known to have no effect on mitochondrial structure, DNA content, or function. There is little information on the side effects of clevudine, which has not been approved for the treatment of chronic hepatitis B outside of South Korea. We report here two cases of chronic hepatitis B patients who experienced mitochondrial myopathy after clevudine medication. These cases raise concerns about the safety profile of clevudine for the treatment of chronic hepatitis B.Keywords
This publication has 10 references indexed in Scilit:
- Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppressionHepatology, 2007
- Twenty‐four‐week clevudine therapy showed potent and sustained antiviral activity in HBeAg‐positive chronic hepatitis B†‡Hepatology, 2007
- A phase II dose-escalating trial of clevudine in patients with chronic hepatitis BHepatology, 2004
- Hepatitis B Virus InfectionNew England Journal of Medicine, 1997
- Inhibition of Epstein-Barr virus replication by a novel l-nucleoside, 2′-fluoro-5-methyl-β-l-arabinofuranosyluracilBiochemical Pharmacology, 1996
- Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracilAntimicrobial Agents and Chemotherapy, 1996
- Structure−Activity Relationships of 1-(2-Deoxy-2-fluoro-β-l-arabino- furanosyl)pyrimidine Nucleosides as Anti-Hepatitis B Virus AgentsJournal of Medicinal Chemistry, 1996
- Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis BNew England Journal of Medicine, 1995
- Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virusAntimicrobial Agents and Chemotherapy, 1995
- Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells.Journal of Clinical Investigation, 1995